Skip to content

Clinical trials

Withdrawn Phase 2 Neoplasm Metastasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 2 Status: Withdrawn Clear all

63 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20064
20075
20082
20092
20105
20111
20134
20144
20167
20173
20182
20193
20203
20212
20222
20233
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn63

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center3
European Organisation for Research and Treatment of Cancer - EORTC2
Hadassah Medical Organization2
SCRI Development Innovations, LLC2
The University of Texas Health Science Center, Houston2
AHS Cancer Control Alberta1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Actuate Therapeutics Inc.1
AdventHealth1
AmpliMed Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis63
Colorectal Neoplasms11
Neoplasms8
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung6
Recurrence6
Carcinoma, Renal Cell5
Rectal Neoplasms5
Brain Neoplasms4
Lung Neoplasms4

Trials

Showing 1 to 25 of 63. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.